MRC2 expression modulates metabolism in acute myeloid leukemia stem cells.
1/5 보강
Leukemic stem cells (LSC) are well recognized for their essential roles in acute myeloid leukemia (AML) initiation and relapse.
APA
Mills TS, Arnone M, et al. (2025). MRC2 expression modulates metabolism in acute myeloid leukemia stem cells.. Cancer letters, 635, 218068. https://doi.org/10.1016/j.canlet.2025.218068
MLA
Mills TS, et al.. "MRC2 expression modulates metabolism in acute myeloid leukemia stem cells.." Cancer letters, vol. 635, 2025, pp. 218068.
PMID
41016679 ↗
Abstract 한글 요약
Leukemic stem cells (LSC) are well recognized for their essential roles in acute myeloid leukemia (AML) initiation and relapse. LSC can be distinguished from non-LSC AML cells by the expression of specific cell surface markers, but there is considerable phenotypic heterogeneity among LSC in AML. Here, using primary patient samples, we report that mannose receptor C-type 2 (MRC2) can be used to enrich for LSC across various AML subtypes. When compared to MRC2- AML cells isolated from the same patient samples, MRC2+ leukemic subpopulations show increased in vitro clonogenic capacity, a stemness transcriptomic signature, and enhanced leukemic capacity in mouse xenograft models. Further, we find that MRC2 is functional on AML cells, and enables their robust uptake of collagen, which supports their glycolytic metabolism. In sum these data highlight the use of functional surface markers to distinguish LSC in AML, and how they can yield insight into their unique characteristics.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
- Leukemia
- Myeloid
- Acute
- Humans
- Neoplastic Stem Cells
- Animals
- Mice
- Glycolysis
- Inbred NOD
- Lectins
- C-Type
- SCID
- Receptors
- Mitogen
- Collagen
- Biomarkers
- Tumor
- Cell Line
- Cell Surface
- Gene Expression Regulation
- Leukemic
- Acute myeloid leukemia
- Leukemia stem cells
- MRC2
… 외 2개
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Associations Between Sex, Disease Features and Outcome in Patients With Acute Myeloid Leukemia: A Sex-Stratified Analysis of the GIMEMA AML1310 Trial.
- Comparative evaluation of two NGS-based assays for somatic hypermutation analysis of IGHV genes in chronic lymphocytic leukemia.
- Asciminib demonstrates superior efficacy and safety in newly diagnosed chronic myeloid leukemia in the ASC4FIRST trial.
- Valproate reactivates HTLV-1 tax and reduces ABCB1/MDR1 expression in PBMCs derived from ATLL patients.
- Counting the Cost: Anticipated Financial Burden and Post-Traumatic Stress Symptoms in Patients Newly Diagnosed with Leukemia and Lymphoma.
- CDK4/6 inhibition overcomes venetoclax resistance mechanisms with enhanced combination activity in acute myeloid leukemia.